Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Supplement: Synergy of Copanlisib with EZH2 inhibition in PIK3CA-driven NSCLCs
Brainson, Christine
(PI)
Toxicology and Cancer Biology
Overview
Fingerprint
Projects & Grants
(1)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Non-Small Cell Lung Cancer
100%
Copanlisib
100%
Tumor
100%
Tazemetostat
83%
Lung Cancer
66%
Organoid
50%
Histology
50%
Protein P53
33%
Health Care Cost
33%
Magnetic Resonance Imaging
33%
Neoplasm
16%
Lung Adenocarcinoma
16%
Agar
16%
Oncogene
16%
In Vitro
16%
Cancer Cell
16%
Tumor Progression
16%
Hyperplasia
16%
Drug Potentiation
16%
Lung Cancer Cell Line
16%
Cell Line
16%
Virus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nude Mouse
100%
Copanlisib
100%
Tazemetostat
71%
Lung Cancer
71%
Protein P53
28%
Virus
14%
Hyperplasia
14%
Tumor Growth
14%
Neoplasm
14%
Agar
14%
Lung Adenocarcinoma
14%
Biochemistry, Genetics and Molecular Biology
EZH2
100%
Nude Mouse
100%
KRAS
57%
Cancer Cell
28%
Magnetic Resonance Imaging
28%
P53
28%
Titer
14%
Agar
14%
Oncogene
14%
Tumor Progression
14%
Drug Potentiation
14%
Virus
14%